Blog

Metonitazene Begins Proliferation as Newest Synthetic Opioid Among Latest Cycle of Non-Fentanyl Related Drugs | Office of Justice Programs

An official website of the United States government, Department of Justice.

Official websites use .gov A .gov website belongs to an official government organization in the United States. C11h14o3

Metonitazene Begins Proliferation as Newest Synthetic Opioid Among Latest Cycle of Non-Fentanyl Related Drugs | Office of Justice Programs

Secure .gov websites use HTTPS A lock ( LockA locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

This alert describes metonitazene, a potent synthetic opioid bearing structural resemblance to etonitazene, a nationally and internationally controlled synthetic opioid.

Metonitazene is a potent synthetic opioid bearing structural resemblance to etonitazene, a synthetic opioid that is nationally and internationally controlled. Metonitazene was first reported by NPS Discovery after detection in a seized drug powder in July 2020. To date, metonitazene has been identified in eight blood specimens associated with postmortem death investigations in the United States. Metonitazene is dissimilar in structure to other synthetic opioids typically encountered in forensic casework (e.g. fentanyl analogues). Metonitazene and similar analogues (e.g. etonitazene, isotonitazene) were first synthesized and reported in the literature in the 1950s. Pharmacological data suggest that this group of synthetic opioids have potency similar to or greater than fentanyl.

Metonitazene Begins Proliferation as Newest Synthetic Opioid Among Latest Cycle of Non-Fentanyl Related Drugs | Office of Justice Programs

C12h12clno3 810 7th St. NW, Washington, D.C. 20531